All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

sodium fluoride F-18 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4488	22554-99-0

Description:

Molecule	Description
Synonyms: sodium fluoride F-18 sodium fluoride-18F sodium fluoride (18F)	Molecular weight: 40.99 Formula: FNa CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Feb. 24, 1972	FDA	GE HEALTHCARE

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Respiratory tract infection bacterial	134.36	48.74	23	471	1759	34954678
Respiratory tract infection viral	132.97	48.74	24	470	2493	34953944
Cytokine release syndrome	98.03	48.74	28	466	22849	34933588
Fibrin D dimer increased	85.07	48.74	18	476	4226	34952211
Respiratory tract infection	83.81	48.74	24	470	19688	34936749

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Respiratory tract infection bacterial	135.66	28.39	23	881	2054	79741430
Respiratory tract infection viral	125.38	28.39	24	880	4235	79739249
Cytokine release syndrome	108.55	28.39	32	872	35966	79707518
Fibrin D dimer increased	76.09	28.39	18	886	8636	79734848
Respiratory tract infection	67.40	28.39	24	880	48665	79694819
Pulmonary embolism	38.51	28.39	24	880	171630	79571854
COVID-19	32.73	28.39	21	883	157653	79585831
C-reactive protein increased	31.35	28.39	19	885	129008	79614476
Thrombocytopenia	31.23	28.39	25	879	265234	79478250
Platelet count decreased	31.02	28.39	22	882	194642	79548842
Hypotension	29.15	28.39	30	874	440287	79303197
Haemoglobin decreased	28.42	28.39	22	882	222097	79521387

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	V09IX06	VARIOUS DIAGNOSTIC RADIOPHARMACEUTICALS TUMOUR DETECTION Other diagnostic radiopharmaceuticals for tumour detection

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
CHEMBL1200744	ChEMBL_ID
9L75099X6R	UNII
1311495	RXNORM
235955	MMSL
26952	MMSL
d07542	MMSL
018450	NDDF
C0304965	UMLSCUI
23690531	PUBCHEM_CID

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	13267-542	INJECTION	600 mCi	INTRAVENOUS	ANDA	17 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	16129-002	INJECTION	200 mCi	INTRAVENOUS	ANDA	18 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	16129-002	INJECTION	200 mCi	INTRAVENOUS	ANDA	18 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	24445-623	INJECTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	24562-002	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	24562-002	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	40028-512	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	23 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	40028-512	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	23 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	40028-512	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	23 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	49609-002	INJECTION	200 mCi	INTRAVENOUS	ANDA	17 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	49609-102	INJECTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	51760-002	INJECTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	52670-550	INJECTION	91.50 mCi	INTRAVENOUS	ANDA	23 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	52670-550	INJECTION	91.50 mCi	INTRAVENOUS	ANDA	23 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	52768-125	INJECTION	200 mCi	INTRAVENOUS	ANDA	26 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	52768-125	INJECTION	200 mCi	INTRAVENOUS	ANDA	26 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	60055-623	INJECTION, SOLUTION	200 mCi	INTRAVENOUS	ANDA	23 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	62072-500	INJECTION	200 mCi	INTRAVENOUS	ANDA	6 sections
Sodium FluorideF18	HUMAN PRESCRIPTION DRUG LABEL	1	65857-300	INJECTION	200 mCi	INTRAVENOUS	ANDA	24 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	67939-020	INJECTION	200 mCi	INTRAVENOUS	ANDA	24 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	67939-020	INJECTION	200 mCi	INTRAVENOUS	ANDA	24 sections
Sodium FluorideF 18 F 18	HUMAN PRESCRIPTION DRUG LABEL	1	76167-002	INJECTION	200 mg	INTRAVENOUS	unapproved drug other	25 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	76419-211	INJECTION	200 mCi	INTRAVENOUS	ANDA	25 sections
Sodium FluorideF 18	HUMAN PRESCRIPTION DRUG LABEL	1	76451-018	INJECTION	200 mCi	INTRAVENOUS	ANDA	7 sections
Sodium Fluoride F 18	HUMAN PRESCRIPTION DRUG LABEL	1	81759-002	INJECTION	200 mCi	INTRAVENOUS	ANDA	17 sections